38
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid

Pages 305-307 | Published online: 12 Jul 2009
 

Abstract

In 15 patients with rheumatoid arthritis (RA) (n = 13) or psoriatic arthritis (PsA) (n = 2) p-homocysteine and erythrocyte folate (erc-FA) were measured before start of methotrexate (MTX ) treatment, after 4 weeks of MTX treatment (median 10 mg per week), and after further 4 weeks of treatment with MTX (median 12.5 mg per week) supplemented with folic acid (FA) (15 mg per week). Mean p-homocysteine were 12.3 &#45 3.4 &#119 mol/l, 14.6 &#45 5.8 &#119 mol/l (p < 0.05) and 10.3 &#45 3.0 &#119 mol/l (p < 0.01) respectively. P-homocysteine concentrations were negative correlated to erc-FA after 4 weeks (rho- 0.58; p< 0.05). It is concluded that treatment with MTX induces a significant rise in p-homocysteine that is neutralised by FA supplementation. Supplementation with FA from the start of MTX treatment is recommended considering the increased risk of cardiovascular disease that is associated with elevated concentrations of p-homocysteine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.